Brief: Knight Therapeutics Reports First Quarter Results

Knight Therapeutics

12/05/2022 12:44

May 12 (Reuters) - Knight Therapeutics Inc  GUD.TO :
    * KNIGHT THERAPEUTICS REPORTS FIRST QUARTER 2022 RESULTS
    * QTRLY BASIC & DILUTED NET LOSS  PER SHARE C$0.16
    * QTRLY REVENUES WERE $63,807, AN INCREASE OF $17,738 OR 39%
OVER
SAME PERIOD IN PRIOR YEAR
    * Q1 EARNINGS PER SHARE VIEW C$-0.04, REVENUE VIEW C$56.4
MILLION
-- REFINITIV IBES DATA
    * ALL FIGURES ARE IN CANADIAN DOLLARS

Source text for Eikon:  ID:nGNX364DjY 
Further company coverage:  GUD.TO 

 ((Reuters.Briefs@thomsonreuters.com;))